Oppenheimer & Co. Inc. increased its position in Enovix Corporation (NASDAQ:ENVX – Free Report) by 58.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 454,446 shares of the company’s stock after buying an additional 166,892 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Enovix were worth $1,318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also added to or reduced their stakes in the business. Sowell Financial Services LLC raised its position in shares of Enovix by 144.1% during the third quarter. Sowell Financial Services LLC now owns 128,995 shares of the company’s stock worth $374,000 after acquiring an additional 76,150 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of Enovix by 96.0% during the third quarter. Inspire Investing LLC now owns 219,586 shares of the company’s stock valued at $637,000 after acquiring an additional 107,563 shares in the last quarter. Parkside Investments LLC raised its holdings in Enovix by 12.0% during the third quarter. Parkside Investments LLC now owns 308,482 shares of the company’s stock worth $895,000 after buying an additional 32,943 shares during the last quarter. Integrated Advisors Network LLC lifted its position in Enovix by 52.5% in the 3rd quarter. Integrated Advisors Network LLC now owns 64,809 shares of the company’s stock valued at $188,000 after acquiring an additional 22,318 shares in the last quarter. Finally, Sax Wealth Advisors LLC acquired a new position in Enovix during the 3rd quarter valued at about $29,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Enovix Price Performance
ENVX stock opened at $3.15 on Monday. The company has a debt-to-equity ratio of 2.46, a quick ratio of 9.37 and a current ratio of 9.71. The company has a market capitalization of $691.27 million, a price-to-earnings ratio of -3.89 and a beta of 2.34. Enovix Corporation has a fifty-two week low of $2.20 and a fifty-two week high of $12.40. The stock has a fifty day moving average of $2.95 and a 200-day moving average of $5.16.
Shares of Enovix are set to split on Friday, November 13th. The 5-4 split was recently announced. The newly minted shares will be payable to shareholders after the closing bell on Thursday, November 12th.
Enovix (NASDAQ:ENVX – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The business had revenue of $9.02 million during the quarter, compared to analyst estimates of $8.43 million. During the same quarter in the previous year, the firm earned ($0.13) EPS. The company’s quarterly revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, equities research analysts predict that Enovix Corporation will post -0.79 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the company. Northland Securities set a $5.00 target price on Enovix in a research report on Tuesday, October 13th. Craig Hallum set a $7.00 price target on Enovix in a research report on Thursday, August 13th. Wall Street Zen cut Enovix from a “sell” rating to a “strong sell” rating in a research note on Saturday. Loop Capital raised shares of Enovix to a “strong-buy” rating in a report on Monday, August 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $25.00 target price on shares of Enovix in a research note on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.77.
About Enovix
Enovix Corporation is a battery technology company that develops lithium-ion batteries using a silicon-anode architecture. Its approach is designed to increase energy density while maintaining safety and cycle-life characteristics through a three-dimensional cell design and a mechanical constraint system that helps manage silicon expansion during charging.
The company’s products are intended for applications that require compact, high-performance power sources, including consumer electronics, wearable devices, Internet of Things equipment, industrial products, and defense and aerospace systems.
Featured Articles
- Five stocks we like better than Enovix
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
